JNJ-95597528

TypeInjection StagePhase 2 Latest updateJan 20, 2026Phase 2 study started

History

Earliest recorded event: Jan 20, 2026. This timeline shows events collected by Eczema Radar and may not include the treatment’s full history. Study details reflect the latest registry record available here.

Jan 20, 2026Phase 2 trial startedA Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis ClinicalTrials.gov NCT07230860

Sources

Trials

READY-AD · NCT07230860Also registered: 2025-523464-20-00